[1] |
SHI Can, CHEN Rong, CHEN Pengzi, WU Tian.
Discussion of the necessity of placing vena cava filter in systemic thrombolytic therapy for patients with acute deep vein thrombosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1413-1418.
|
[2] |
QIN Wenjie, YANG Zhiling, CAO Ailin, GAO Hang, JIANG Xianrui, SHEN Yue, QIAN Jiao.
Advances in the study of new oral anticoagulants in cancer-associated venous thromboembolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 823-828.
|
[3] |
LIU Wengui, WANG Youjin, MA Kun, DAI Guoliang, SHEN Xianglei, WANG Wei, SI Haipeng.
Effects of elemene injected in multiple ways on liver histology changes in rabbits
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 277-282.
|
[4] |
ZHENG Qiluan, SHEN Qi, YU Jincong, YUAN Yao, CHEN Bo.
Effects of rivaroxaban combined with Xuesaitong injection on deep venous thrombosis of lower extremity after spinal trauma surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 337-341.
|
[5] |
JI Na, ZHANG Gen-bao, HUANG Lu, WANG Fei, ZHANG Ya, WU Juan.
Effects of platelet inhibitor from Agkistrodon halys venom on artery thrombosis in rabbit
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 987-990.
|
[6] |
CHENG Min, YE Xiao-di, MIAO Yun-ping, CHEN Ai-yin, ZHENG Gao-li.
Experimental study of Pearl Bright Eyedrop on rabbit eyes ameliorating microcirculation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(8): 856-859.
|
[7] |
ZHOU Peng, SUN Yuan, ZHANG Shu-xia, XIA Ai-xiao, CHEN Sai-zhen, DU You-gong.
Pharmacokinetic study of glipizide effected by roxithromycin in rabbits
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(2): 181-184.
|
[8] |
HUANG Lu, ZHANG Gen-bao, MIN Zhi-xue, MA Kai-ran, ZHENG Ru-qi, SUN Yao, WU Juan.
Effect and mechanism of platelet inhibitor from Agkistrodon halys venom on artery thrombosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(12): 1355-1360.
|
[9] |
LUAN Hai-yun, LI Jin-lian, WANG Shao-hua, ZHONG Wei-zhen, HAN Yan-tao.
Determination of L-carnitine and its active metabolites in rabbit plasma and hepatic tissue by precolumn derivatization HPLC
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(6): 636-640.
|
[10] |
YAN Shou-sheng, GONG Xin-jiang, GUO Yong-qi, LI Jian-feng, WU Guo-dong, WANG Qing-min, SUN Li-xia, YANG Qing-min, WANG Jing-yi.
Thrombolysis activities of desmoteplase and mutants expressed in yeast Pichia methanolica
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(6): 645-650.
|
[11] |
DENG Shao-xiong, ZHENG Yuan, GUO Nan-ou.
Influence of atorvastatin on the curative effect and restenosis in patients with acute myocardial infarction for postoperative percutaneous coronary intervention
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 199-203.
|
[12] |
WANG Ya-min.
Progression of sulodexide and clinical application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(1): 109-115.
|
[13] |
KE Yong-sheng.
Novel anticoagulant, direct factor Xa inhibitor: Rivaroxaban
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(4): 361-367.
|
[14] |
DENG Zu-yue, KANG Hua, XIN Yan-fei, KUANG Rong.
Effects of tea polyphenols on the serum lipid and inflammation factor in experimental atherosclerosis rabbits
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(3): 279-282.
|
[15] |
LI Hua, CHEN Ling-xia, XU Rui-an.
Pharmaceutical methods of identifying fibrinolytic activity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(9): 1066-1070.
|